slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,539
Current window 86,191-86,220
Pages 3,685
Rows per page 30
Component
86,191-86,220 of 110,539
19
The slide uses donut charts to visualize the split between 3rd party suppliers and vertically integrated manufacturing for specific vehicle types.Proterra | Investor Presentation Deck | 28 slides · Proterra
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
25
The slide uses a dual-track approach: quantitative funding growth on the left and qualitative regulatory/corporate mandates on the right.Proterra | Investor Presentation Deck | 28 slides · Proterra
Pitch deck Investor relations Loop · Why Now1 hit
26
Uses historical data to build credibility for the impact of the IRA.Proterra | Investor Presentation Deck | 28 slides · Proterra
Pitch deck Investor relations Loop · Why Now1 hit
16
Background is a watermark of US dollar bills.SiriusXM | Investor Day Presentation Deck | 19 slides · SiriusXM
Conference presentation Investor relations Beat · Financials1 hit
03
Includes a disclaimer regarding non-GAAP measures.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Attention1 hit
04
Sonos | Results Presentation Deck | 41 slidesSonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations 1 hit
05
Sonos | Results Presentation Deck | 41 slidesSonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations 1 hit
08
The table includes fiscal year data for households, product registrations, products per household, and listening hours.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Need1 hit
09
The table provides a reconciliation of GAAP to Non-GAAP operating expenses, highlighting the impact of stock-based compensation, restructuring, and legal/transaction costs.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Need1 hit
10
Includes a disclaimer regarding non-GAAP measures and rounding.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Need1 hit
12
Sonos | Results Presentation Deck | 41 slidesSonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Satisfaction1 hit
15
The slide uses a bar chart to show historical margin performance and a future guidance point.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Satisfaction1 hit
16
The table provides a detailed breakdown of R&D, S&M, and G&A expenses, adjusting for stock-based compensation, restructuring, and legal/transaction costs.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Satisfaction1 hit
18
Sonos | Results Presentation Deck | 41 slidesSonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
28
The slide uses a custom flywheel-style diagram to illustrate the relationship between growth drivers and market conditions.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Action1 hit
35
The slide highlights a strategic shift toward higher-margin channels (DTC and IS) which now account for 44% of total revenue.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Action1 hit
06
The slide outlines the value proposition of a specific business partnership.Taboola | Mergers and Acquisitions Presentation Deck | 13 slides · Taboola
Shareholder letter Investment bank Beat · Complication1 hit
04
Theravance Biopharma | Investor Conference Presentation Deck | 44 slidesTheravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
05
Theravance Biopharma | Investor Conference Presentation Deck | 44 slidesTheravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
11
The slide uses a process flow diagram to show how patients transition from Study 0169 to 0170.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
16
Includes a footer with abbreviations for BP, DHPG, MSA, NE, and nOH.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
19
The slide highlights the failure of Study 0169 and the subsequent early termination of Study 0170.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
21
The slide uses a flow diagram to illustrate study design and participant disposition.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
24
The slide uses a forest plot to visualize the odds ratio (0.60) with a 95% confidence interval (0.27, 1.29) crossing the null value of 1.0.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
25
Uses a visual comparison to explain the biological mechanism of action.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
28
The slide includes a table of adverse events and bulleted takeaways regarding clinical safety parameters.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
32
The slide uses a bulleted list to frame the clinical trial narrative from failure to a focused subgroup opportunity.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
33
The slide uses a biological mechanism diagram to illustrate the drug's effect on norepinephrine reuptake.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
34
The slide outlines a clinical trial program involving three studies (0169, 0170, 0171) with specific eligibility criteria and endpoints for a longitudinal analysis.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
44
The slide uses a tree metaphor for the study name 'CYPRESS'.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit